Activating transcription factor 3 inhibits NF‑κB p65 signaling pathway and mediates apoptosis and cell cycle arrest in cervical cancer cells

BACKGROUND: As a novel tumor suppressor mediator, activating transcription factor 3 (ATF3) has recently aroused an interest in its possible therapeutic applications in various cancers. In this study, we evaluated the effect of ATF3 overexpression on the cellular level of nuclear factor kappa B (NF-κ...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbarpour Arsanjani, Amirhossein, Abuei, Haniyeh, Behzad-Behbahani, Abbas, Bagheri, Zahra, Arabsolghar, Rita, Farhadi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753250/
https://www.ncbi.nlm.nih.gov/pubmed/36522783
http://dx.doi.org/10.1186/s13027-022-00475-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753250/
https://www.ncbi.nlm.nih.gov/pubmed/36522783
http://dx.doi.org/10.1186/s13027-022-00475-7

Ejemplares similares